Overall Status

Completed (34)

Terminated (16)

Active, not recruiting (2)

Withdrawn (1)

Phase

phase 2 (27)

phase 1 (15)

phase 1/phase 2 (4)

n/a (3)

phase 3 (3)

early phase 1 (1)

Collaborator

National Cancer Institute (NCI) (20)

Rutgers Cancer Institute of New Jersey (2)

Amgen (1)

Fred Hutchinson Cancer Center (1)

GlaxoSmithKline (1)

Teva Pharmaceutical Industries, Ltd. (1)

Study Documents

Intervention Type

drug (51)

other (27)

procedure (7)

biological (6)

dietary supplement (1)

radiation (1)

Funder Type

Other (27)

NIH (25)

Industry (1)

Study Type

Interventional (53)

adult acute myeloblastic leukemia without maturation (m1)

Showing 51 - 53 of 53

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed

Adult Acute Megakaryoblastic Leukemia (M7)
+16 more

tipifarnib

San Antonio, Texas

Southwest Oncology Group

Jan 14, 2013

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed

Adult Acute Megakaryoblastic Leukemia (M7)
+14 more

Baltimore, Maryland

Johns Hopkins University

Jan 8, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic

Completed

Accelerated Phase Chronic Myelogenous Leukemia
+72 more

busulfan
+5 more

Cleveland, Ohio

Ireland Cancer Center at University Hospitals Case Medical Cente

Aug 5, 2010